Erez Chimovits
Independent DirectorMr. Erez Chimovits, M.Sc., M.B.A., serves as Independent Director at ADARx Pharmaceuticals, Inc. since May 2020 and serves as its Interim Chairman. He is Director of Azura Ophthalmics Ltd. is Director of Braveheart Bio, Inc. since September 2025. He is Director of FORE US Bio Inc. and Fore Biotherapeutics Inc. He serves as Chairman of the Board of GentiBio, Inc. since 2022 and had been Director since 2022 until 2022. He serves as a Director at FutuRX since 2022. He serves as a Partner at OrbiMed Advisors, L.L.C. since 2020. He is Director at MiroBio Ltd. He serves as an Independent Director of Upstream Bio Inc. since October 2021. He served as Senior Managing Director of OrbiMed Advisors LLC from November 2010 to 2020. He had been an Independent Director at Galecto, Inc. since 2020. He serves as Senior Managing Director of Orbimed Healthcare Fund Management. Prior to joining OrbiMed, he served as the Chief Executive Officer at NasVax Ltd. since joining it in 2007. He served as the Chief Executive Officer of Therapix Biosciences Ltd. He spent extensive period with Compugen. He joined Compugen Ltd. as Director of Marketing & Sales in 1999. He also served as Vice President of Marketing & Sales of Compugen Inc. since June 2001. He has significant operational experience, including a decade of senior Managerial experience in public companies. He served as an Executive Vice President of Commercial Operations at Compugen Ltd. since June 2001. He served as the President of Compugen USA, Inc. since August 2001 and also served as its President of the Bio-Applications division. At Compugen, he had P&L responsibility for more than 100 people and led multiple transactions including J&J, Novartis, Teva, Abbott, Medarex and others. He held various positions in business development, marketing and sales at Saifan Ltd. He served as Chairman at FutuRX till 2022. He served as the Chairman of Otic Pharma Ltd. He served as Chairman at Novus Therapeutics, Inc. He had been Independent Director at Novus Therapeutics, Inc. since May 2017 until September 9, 2020. He serves as an Independent Director at RDD Pharma, Ltd. since May 2017. He served as an Independent Director at BiomX Inc. since October 2019 until October 2, 2020. He served as a Director of Atox Bio Inc. until March 2022. He served as a Director of Emendo Bio, Inc. He served as a Member of the Board of Directors of Adicet Bio, Inc. since September 15, 2020 until March 02, 2021. He served as Chairman of GentiBio, Inc. until 2022. He served as a Director of LogicBio Therapeutics, Inc. since January 2016 until December 10, 2020. He serves as a Director at cCAM Biotherapeutics Ltd. and Nucleix, Ltd. He served as a Director at MediGus Ltd. since March 3, 2013. He holds an M.B.A., M.Sc. in Microbiology and a B.Sc. in Molecular Biology from Tel Aviv University, Israel.
Positions
- Company NameUpstream Bio, Inc.Stock CodeUPBPositionIndependent DirectorColleagues
- ERE. Rand SutherlandCEO & Director
- RCRonald C. RenaudIndependent Chairman of the Board
- MPMichael Paul GrayCFO & COO
- ADAaron DeykinChief Medical Officer and Head of Research & Development
- SPStacy PriceChief Technology Officer
- MBMeggan BuckwellDirector of Corporate Communications & Investor Relations
- MKMarcella Kuhlman RuddyIndependent Director
- DBDaniella BeckmanIndependent Director
- Company NameBraveheart Bio, Inc.Stock CodeBRVEPositionIndependent DirectorColleagues
- TMTravis MurdochCEO, President & Director
- CAChristopher A. ViehbacherIndependent Chairman
- JPJames Paul RickeyChief Financial Officer
- MAMichele A. AndersonChief Development Officer
- MEMarc EvanchikChief Scientific Officer
- NDNatalie DementVP & Head of Legal
- JMJasper M. BosIndependent Director
- DCDavid Charles LubnerIndependent Director
- ECErez ChimovitsIndependent Director
- Company NameADARx Pharmaceuticals, Inc.Stock CodeADRXPositionInterim Independent ChairmanColleagues
- LZLi ZhenCo-Founder, President, CEO & Director
- ECErez ChimovitsInterim Independent Chairman
- ARA. Robert MacLeodChief Scientific Officer
- RFRyan FiskCFO & Chief Business Officer
- CCChristopher ClaeboeSenior Vice President of Operations
- RZRui ZhuChief Technology Officer
- CLCarl Lee GordonIndependent Director
- SJSimeon John GeorgeIndependent Director
- YHYing HuangIndependent Director
